These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. de Graaf JH; Tamminga RY; Kamps WA; Timens W Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361 [TBL] [Abstract][Full Text] [Related]
26. Solitary congenital self-healing Langerhans cell histiocytosis: a benign variant of Langerhans cell histiocytosis? Yurkovich M; Wong A; Lam JM Dermatol Online J; 2013 Jan; 19(1):3. PubMed ID: 23374945 [TBL] [Abstract][Full Text] [Related]
27. Langerhans cell histiocytosis: Current concepts and treatments. Abla O; Egeler RM; Weitzman S Cancer Treat Rev; 2010 Jun; 36(4):354-9. PubMed ID: 20188480 [TBL] [Abstract][Full Text] [Related]
28. Current controversies. Histiocytosis-X. McLelland J; Pritchard J; Chu AC Hematol Oncol Clin North Am; 1987 Mar; 1(1):147-62. PubMed ID: 3312146 [TBL] [Abstract][Full Text] [Related]
29. The scientific challenge of Langerhans cell histiocytosis. Beverley PC; Abbas AK Br J Cancer Suppl; 1994 Sep; 23():S61-3. PubMed ID: 8075011 [TBL] [Abstract][Full Text] [Related]
30. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Nezelof C; Basset F Pediatr Blood Cancer; 2004 May; 42(5):398-400. PubMed ID: 15049008 [No Abstract] [Full Text] [Related]
31. Pathogenesis of Langerhans cell histiocytosis. Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202 [TBL] [Abstract][Full Text] [Related]
32. Langerhans cell histiocytosis arising from a BCC: a case report and review of the literature. Patel P; Talpur R; Duvic M Cutis; 2010 Jun; 85(6):295-300. PubMed ID: 20666189 [TBL] [Abstract][Full Text] [Related]
34. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. McClain KL; Laud P; Wu WS; Pollack MS Med Pediatr Oncol; 2003 Dec; 41(6):502-7. PubMed ID: 14595706 [TBL] [Abstract][Full Text] [Related]
35. Isolated Langerhans cell histiocytosis of the sublingual gland in an adult. Yang S; Chen X; Zhang J; Fang Q Int J Clin Exp Pathol; 2015; 8(10):13647-50. PubMed ID: 26722591 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Lau SK; Chu PG; Weiss LM Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880 [TBL] [Abstract][Full Text] [Related]
37. A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis. Mitchell JM; Berzins SP; Kannourakis G Clin Immunol; 2018 Sep; 194():19-25. PubMed ID: 29928999 [TBL] [Abstract][Full Text] [Related]
38. Disseminated form of Langerhans cell histiocytosis discovered in stomatological examination--a case report. Łangowska-Adamczyk H; Jedrusik-Pawłowska M Med Sci Monit; 2000; 6(6):1174-8. PubMed ID: 11208476 [TBL] [Abstract][Full Text] [Related]
39. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Berres ML; Merad M; Allen CE Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560 [TBL] [Abstract][Full Text] [Related]
40. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis. Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]